These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1736809)

  • 41. Recombinant superoxide dismutase (SOD) administered by aerosol inhibits respiratory syncytial virus infection in cotton rats.
    Wyde PR; Moore DK; Pimentel DM; Gilbert BE; Nimrod R; Panet A
    Antiviral Res; 1996 Jul; 31(3):173-84. PubMed ID: 8811202
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lack of interference of guanosine with ribavirin aerosol treatment of influenza A infection in mice.
    Knight V; Wilson SZ; Alling DW; Moore RV; Longoria RM
    Antimicrob Agents Chemother; 1981 Oct; 20(4):477-80. PubMed ID: 6282193
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of mannan-enhanced influenza B virus infections in mice with oseltamivir, ribavirin and viramidine.
    Smee DF; Wandersee MK; Wong MH; Bailey KW; Sidwell RW
    Antivir Chem Chemother; 2004 Sep; 15(5):261-8. PubMed ID: 15535048
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aerosolized ribavirin treatment of respiratory syncytial virus infection in infants hospitalized during an epidemic.
    Conrad DA; Christenson JC; Waner JL; Marks MI
    Pediatr Infect Dis J; 1987 Feb; 6(2):152-8. PubMed ID: 3562136
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exposure of health care workers to ribavirin during therapy for respiratory syncytial virus infections.
    Bradley JS; Connor JD; Compogiannis LS; Eiger LL
    Antimicrob Agents Chemother; 1990 Apr; 34(4):668-70. PubMed ID: 2344173
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections.
    Sparrelid E; Ljungman P; Ekelöf-Andström E; Aschan J; Ringdén O; Winiarski J; Wåhlin B; Andersson J
    Bone Marrow Transplant; 1997 May; 19(9):905-8. PubMed ID: 9156264
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiviral activity of NMSO3 against respiratory syncytial virus infection in vitro and in vivo.
    Kimura K; Mori S; Tomita K; Ohno K; Takahashi K; Shigeta S; Terada M
    Antiviral Res; 2000 Jul; 47(1):41-51. PubMed ID: 10930645
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study.
    Hall CB; McBride JT; Walsh EE; Bell DM; Gala CL; Hildreth S; Ten Eyck LG; Hall WJ
    N Engl J Med; 1983 Jun; 308(24):1443-7. PubMed ID: 6343860
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201.
    Sidwell RW; Smee DF; Huffman JH; Barnard DL; Bailey KW; Morrey JD; Babu YS
    Antimicrob Agents Chemother; 2001 Mar; 45(3):749-57. PubMed ID: 11181355
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants.
    Taber LH; Knight V; Gilbert BE; McClung HW; Wilson SZ; Norton HJ; Thurson JM; Gordon WH; Atmar RL; Schlaudt WR
    Pediatrics; 1983 Nov; 72(5):613-8. PubMed ID: 6356005
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The use of a virazole aerosol in young children with a respiratory syncytial virus infection].
    Cheshik SG; Vartanian RV; Ivanova LA; Kisteneva LB; Galegov GA
    Vopr Virusol; 1992; 37(2):97-9. PubMed ID: 1441436
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aerosol treatment of respiratory viral disease.
    Knight V; Gilbert BE
    Lung; 1990; 168 Suppl():406-13. PubMed ID: 2117142
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ribavirin for severe RSV infection.
    N Engl J Med; 1991 Dec; 325(26):1884-6. PubMed ID: 1961230
    [No Abstract]   [Full Text] [Related]  

  • 54. Ribavirin aerosol approved for severe cases of RSV in infants and young children.
    FDA Drug Bull; 1986 Jun; 16(1):7. PubMed ID: 3732682
    [No Abstract]   [Full Text] [Related]  

  • 55. Serum High-Mobility-Group Box 1 as a Biomarker and a Therapeutic Target during Respiratory Virus Infections.
    Patel MC; Shirey KA; Boukhvalova MS; Vogel SN; Blanco JCG
    mBio; 2018 Mar; 9(2):. PubMed ID: 29535197
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical applications of antiviral agents for chemophrophylaxis and therapy of respiratory viral infections.
    Hayden FG
    Antiviral Res; 1985; Suppl 1():229-39. PubMed ID: 2417551
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Short duration aerosols of JNJ 2408068 (R170591) administered prophylactically or therapeutically protect cotton rats from experimental respiratory syncytial virus infection.
    Wyde PR; Chetty SN; Timmerman P; Gilbert BE; Andries K
    Antiviral Res; 2003 Nov; 60(3):221-31. PubMed ID: 14638398
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibitory effects of recombinant manganese superoxide dismutase on influenza virus infections in mice.
    Sidwell RW; Huffman JH; Bailey KW; Wong MH; Nimrod A; Panet A
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2626-31. PubMed ID: 8913477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ribavirin aerosol treatment of influenza B virus infection.
    McClung HW; Knight V; Gilbert BE; Wilson SZ; Quarles JM; Couch RB; Divine GW; Gordon WH; Thurston JM; Atmar RL
    Trans Assoc Am Physicians; 1983; 96():284-93. PubMed ID: 6093312
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MegaRibavirin aerosol for the treatment of influenza A virus infections in mice.
    Gilbert BE; McLeay MT
    Antiviral Res; 2008 Jun; 78(3):223-9. PubMed ID: 18281104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.